Form 8-K - Current report:
SEC Accession No. 0001493152-22-016803
Filing Date
2022-06-15
Accepted
2022-06-15 09:00:12
Documents
12
Period of Report
2022-06-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 37973
  Complete submission text file 0001493152-22-016803.txt   211530

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE envb-20220613.xsd EX-101.SCH 2956
3 XBRL LABEL FILE envb-20220613_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE envb-20220613_pre.xml EX-101.PRE 22357
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3743
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38286 | Film No.: 221016698
SIC: 2834 Pharmaceutical Preparations